Consolidated Balance Sheets - USD ($)	Mar. 31, 2025	Dec. 31, 2024
Current assets
Cash	$ 20,687,806	$ 15,878,295
Inventory, net	3,159,382	2,753,032
Convertible loan receivable		1,101,478
Prepaid and other assets	1,091,039	1,123,798
Total current assets	36,842,548	33,305,988
Long-term assets
Intangible assets, net	42,013,997	41,006,776
Goodwill	3,601,781	3,601,781
Investment in equity securities	10,690,283	8,297,223
Right of use assets – operating leases	1,173,851	1,447,907
Property and equipment, net	2,056,121	432,317
Total long-term assets	59,536,033	54,786,004
Total assets	96,378,581	88,091,992
Current liabilities
Accrued bonuses and commissions	8,212,379	10,778,840
Accrued royalties and expenses	2,701,561	2,621,867
Operating lease liabilities – current	229,710	358,687
Total current liabilities	13,281,055	15,290,071
Long-term liabilities
Long-term debt	43,402,223	30,689,290
Earnout liabilities – long-term	771,001	748,001
Operating lease liabilities – long-term	1,087,947	1,237,051
Other long-term liabilities	1,168,778	1,215,617
Total long-term liabilities	46,429,949	33,889,959
Total liabilities	59,711,004	49,180,030
Shareholders’ equity
Common Stock: $0.001 par value, 20,000,000 shares authorized; 8,903,630 issued and outstanding as of March 31, 2025 and 8,753,773 issued and outstanding as of December 31, 2024	8,904	8,754
Additional paid-in capital	77,973,673	77,179,211
Accumulated deficit	(41,311,569)	(37,784,392)
Total Sanara MedTech shareholders’ equity	36,671,008	39,403,573
Equity attributable to noncontrolling interest	(3,431)	(491,611)
Total shareholders’ equity	36,667,577	38,911,962
Total liabilities and shareholders’ equity	96,378,581	88,091,992
Nonrelated Party [Member]
Current assets
Accounts receivable	11,861,502	12,408,819
Current liabilities
Accounts payable	2,095,600	1,499,764
Related Party [Member]
Current assets
Accounts receivable	42,819	40,566
Current liabilities
Accounts payable	$ 41,805	$ 30,913